These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26530518)

  • 1. Bayesian meta-analytical methods to incorporate multiple surrogate endpoints in drug development process.
    Bujkiewicz S; Thompson JR; Riley RD; Abrams KR
    Stat Med; 2016 Mar; 35(7):1063-89. PubMed ID: 26530518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints.
    Bujkiewicz S; Thompson JR; Spata E; Abrams KR
    Stat Methods Med Res; 2017 Oct; 26(5):2287-2318. PubMed ID: 26271918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivariate network meta-analysis for surrogate endpoint evaluation.
    Bujkiewicz S; Jackson D; Thompson JR; Turner RM; Städler N; Abrams KR; White IR
    Stat Med; 2019 Aug; 38(18):3322-3341. PubMed ID: 31131475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian hierarchical surrogate outcome model for multiple sclerosis.
    Pozzi L; Schmidli H; Ohlssen DI
    Pharm Stat; 2016 Jul; 15(4):341-8. PubMed ID: 27061897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of copula to model within-study association in bivariate meta-analysis of binomial data at the aggregate level: A Bayesian approach and application to surrogate endpoint evaluation.
    Papanikos T; Thompson JR; Abrams KR; Bujkiewicz S
    Stat Med; 2022 Nov; 41(25):4961-4981. PubMed ID: 35932152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian hierarchical meta-analytic methods for modeling surrogate relationships that vary across treatment classes using aggregate data.
    Papanikos T; Thompson JR; Abrams KR; Städler N; Ciani O; Taylor R; Bujkiewicz S
    Stat Med; 2020 Apr; 39(8):1103-1124. PubMed ID: 31990083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Framework for personalized prediction of treatment response in relapsing remitting multiple sclerosis.
    Stühler E; Braune S; Lionetto F; Heer Y; Jules E; Westermann C; Bergmann A; van Hövell P;
    BMC Med Res Methodol; 2020 Feb; 20(1):24. PubMed ID: 32028898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trials.
    Renfro LA; Shi Q; Sargent DJ; Carlin BP
    Stat Med; 2012 Apr; 31(8):743-61. PubMed ID: 22161275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach.
    Sormani MP; Bonzano L; Roccatagliata L; Mancardi GL; Uccelli A; Bruzzi P
    Neurology; 2010 Jul; 75(4):302-9. PubMed ID: 20574036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate meta-analysis of mixed outcomes: a Bayesian approach.
    Bujkiewicz S; Thompson JR; Sutton AJ; Cooper NJ; Harrison MJ; Symmons DP; Abrams KR
    Stat Med; 2013 Sep; 32(22):3926-43. PubMed ID: 23630081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables.
    Jiang Z; Song Y; Shou Q; Xia J; Wang W
    Trials; 2014 Dec; 15():500. PubMed ID: 25528466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpoints.
    Alonso A; Molenberghs G; Burzykowski T; Renard D; Geys H; Shkedy Z; Tibaldi F; Abrahantes JC; Buyse M
    Biometrics; 2004 Sep; 60(3):724-8. PubMed ID: 15339295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian bivariate meta-analysis of correlated effects: Impact of the prior distributions on the between-study correlation, borrowing of strength, and joint inferences.
    Burke DL; Bujkiewicz S; Riley RD
    Stat Methods Med Res; 2018 Feb; 27(2):428-450. PubMed ID: 26988929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The choice of prior distribution for a covariance matrix in multivariate meta-analysis: a simulation study.
    Hurtado Rúa SM; Mazumdar M; Strawderman RL
    Stat Med; 2015 Dec; 34(30):4083-104. PubMed ID: 26303671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive probability of success using surrogate endpoints.
    Saint-Hilary G; Barboux V; Pannaux M; Gasparini M; Robert V; Mastrantonio G
    Stat Med; 2019 May; 38(10):1753-1774. PubMed ID: 30548627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the relationship between the causal-inference and meta-analytic paradigms for the evaluation of surrogate endpoints.
    Van der Elst W; Molenberghs G; Alonso A
    Stat Med; 2016 Apr; 35(8):1281-98. PubMed ID: 26612787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
    Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008933. PubMed ID: 23744561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate endpoints for EDSS worsening in multiple sclerosis: a meta-analytic approach: measuring disability in relapsing-remitting MS.
    Ebers GC; Daumer M; Scalfari A
    Neurology; 2011 Mar; 76(11):1025; author reply 1025-6. PubMed ID: 21403116
    [No Abstract]   [Full Text] [Related]  

  • 20. Bayesian multivariate meta-analysis with multiple outcomes.
    Wei Y; Higgins JP
    Stat Med; 2013 Jul; 32(17):2911-34. PubMed ID: 23386217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.